Long-Term Real-World Outcomes of Mepolizumab and Benralizumab Among Biologic-Naive Patients With Severe Eosinophilic Asthma: Experience of 3 Years’ Therapy

Fred Fyles, Amy Nuttall, Hannah Joplin, Hassan Burhan

2023The Journal of Allergy and Clinical Immunology In Practice16 citationsDOI

Topics & Concepts

MedicineMepolizumabExacerbationAsthmaInternal medicineBenralizumabQuality of life (healthcare)Asthma exacerbationsEosinophilNursingAsthma and respiratory diseasesEosinophilic EsophagitisIL-33, ST2, and ILC Pathways